Hemochromatosis News and Research

RSS
Hemochromatosis is the most common form of iron overload disease. Primary hemochromatosis, also called hereditary hemochromatosis, is an inherited disease. Secondary hemochromatosis is caused by anemia, alcoholism, and other disorders.

Juvenile hemochromatosis and neonatal hemochromatosis are two additional forms of the disease. Juvenile hemochromatosis leads to severe iron overload and liver and heart disease in adolescents and young adults between the ages of 15 and 30. The neonatal form causes rapid iron buildup in a baby’s liver that can lead to death.
Kyoto University researchers identify specific gene as key regulator in iron uptake

Kyoto University researchers identify specific gene as key regulator in iron uptake

Opportunities and risks of direct-to-consumer genetic health risk tests

Opportunities and risks of direct-to-consumer genetic health risk tests

FDA authorizes marketing of first direct-to-consumer GHR tests for certain diseases

FDA authorizes marketing of first direct-to-consumer GHR tests for certain diseases

Researchers identify key hormone critical for preventing spread of bacterial pneumonia

Researchers identify key hormone critical for preventing spread of bacterial pneumonia

Mildly elevated body iron contributes to prevalence and incidence of type 2 diabetes

Mildly elevated body iron contributes to prevalence and incidence of type 2 diabetes

Minihepcidins may potentially treat serious genetic blood diseases in children, adults

Minihepcidins may potentially treat serious genetic blood diseases in children, adults

Invitae announces dramatic expansion of genetic testing menu

Invitae announces dramatic expansion of genetic testing menu

CLDF collaborates with Walgreens to offer free rapid HCV testing

CLDF collaborates with Walgreens to offer free rapid HCV testing

Minihepcidin reverses iron overload of hemochromatosis, stops susceptibility to infections

Minihepcidin reverses iron overload of hemochromatosis, stops susceptibility to infections

People with iron overload disease are more vulnerable to Vibrio vulnificus infections

People with iron overload disease are more vulnerable to Vibrio vulnificus infections

Keryx Biopharmaceuticals supplies AURYXIA tablets to wholesalers in US

Keryx Biopharmaceuticals supplies AURYXIA tablets to wholesalers in US

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Argininosuccinic aciduria (ASA) and gene therapy: an interview with Dr Julien Baruteau, UCL Institute for Women's Health, London

Argininosuccinic aciduria (ASA) and gene therapy: an interview with Dr Julien Baruteau, UCL Institute for Women's Health, London

NAFLD is an independent predictor of cardiovascular risk

NAFLD is an independent predictor of cardiovascular risk

Two studies shed light on molecular biology of three blood disorders

Two studies shed light on molecular biology of three blood disorders

Researchers to develop new diagnostic tools and treatments for people with rare diseases

Researchers to develop new diagnostic tools and treatments for people with rare diseases

Liver transplantations for NASH-Cirrhosis increase dramatically

Liver transplantations for NASH-Cirrhosis increase dramatically

Cancer researchers create catalog of possible targets for new treatments

Cancer researchers create catalog of possible targets for new treatments

Public health officials should address needs of people with blood disorders

Public health officials should address needs of people with blood disorders

Scientists identify 28 blood pressure-associated genetic variants

Scientists identify 28 blood pressure-associated genetic variants